The clinical course of patients with previous acute and recurrent pericarditis receiving the BNT162b2 vaccine

•Pericarditis has been reported following the BNT162b2 vaccine.•The safety of BNT162b2 in patients with previous pericarditis is unknown.•Some cases of mild symptoms following BNT162b2 in previous pericarditis were seen.•Pericarditis recurrence was seen in 2 of 64 patients, who both had a recently active disease.